{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:29:55Z","timestamp":1774625395471,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,6]]},"DOI":"10.7759\/cureus.80184","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:24:17Z","timestamp":1741332257000},"source":"Crossref","is-referenced-by-count":1,"title":["Cholecystectomy Is Linked to Worse Clinical Outcomes in Primary Sclerosing Cholangitis"],"prefix":"10.7759","author":[{"given":"Nozomi","family":"Miyake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Yasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis KN","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016, 375:1161-70. 10.1056\/NEJMra1506330","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen TH","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017, 67:1298-323. 10.1016\/j.jhep.2017.07.022","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson JK","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018, 391:2547-59. 10.1016\/S0140-6736(18)30300-3","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton JE","year":"2013","unstructured":"Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013, 145:521-36. 10.1053\/j.gastro.2013.06.052","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1411372","article-title":"Interventional approaches to gallbladder disease","volume":"373","author":"Baron TH","year":"2015","unstructured":"Baron TH, Grimm IS, Swanstrom LL. Interventional approaches to gallbladder disease. N Engl J Med. 2015, 373:357-65. 10.1056\/NEJMra1411372","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150050","article-title":"Functions of the gallbladder","volume":"6","author":"Housset C","year":"2016","unstructured":"Housset C, Chr\u00e9tien Y, Debray D, Chignard N. Functions of the gallbladder. Compr Physiol. 2016, 6:1549-77. 10.1002\/cphy.c150050","journal-title":"Compr Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2021.101130","article-title":"Gallbladder disorders: a comprehensive review","volume":"67","author":"Lam R","year":"2021","unstructured":"Lam R, Zakko A, Petrov JC, Kumar P, Duffy AJ, Muniraj T. Gallbladder disorders: a comprehensive review. Dis Mon. 2021, 67:101130. 10.1016\/j.disamonth.2021.101130","journal-title":"Dis Mon"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597818","article-title":"Regenerative medicine and the biliary tree","volume":"37","author":"De Assuncao TM","year":"2017","unstructured":"De Assuncao TM, Jalan-Sakrikar N, Huebert RC. Regenerative medicine and the biliary tree. Semin Liver Dis. 2017, 37:17-27. 10.1055\/s-0036-1597818","journal-title":"Semin Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01568-8","article-title":"Gallbladder-derived retinoic acid signalling drives reconstruction of the damaged intrahepatic biliary ducts","volume":"27","author":"He J","year":"2025","unstructured":"He J, Li S, Yang Z, et al.. Gallbladder-derived retinoic acid signalling drives reconstruction of the damaged intrahepatic biliary ducts. Nat Cell Biol. 2025, 27:39-47. 10.1038\/s41556-024-01568-8","journal-title":"Nat Cell Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adw3651","article-title":"Rebuilding duct work from the gallbladder","volume":"18","author":"Wong W","year":"2025","unstructured":"Wong W. Rebuilding duct work from the gallbladder. Sci Signal. 2025, 18:eadw3651. 10.1126\/scisignal.adw3651","journal-title":"Sci Signal"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4065\/75.7.688","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim WR","year":"2000","unstructured":"Kim WR, Therneau TM, Wiesner RH, et al.. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000, 75:688-94. 10.4065\/75.7.688","journal-title":"Mayo Clin Proc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard A","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al.. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007, 46:32-6. 10.1002\/hep.21669","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120019","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian JH","year":"2013","unstructured":"Tabibian JH, Masyuk AI, Masyuk TV, O'Hara SP, LaRusso NF. Physiology of cholangiocytes. Compr Physiol. 2013, 3:541-65. 10.1002\/cphy.c120019","journal-title":"Compr Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich M","year":"2021","unstructured":"Reich M, Spomer L, Klindt C, et al.. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. J Hepatol. 2021, 75:634-46. 10.1016\/j.jhep.2021.03.029","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1810819115","article-title":"Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip","volume":"115","author":"Shin W","year":"2018","unstructured":"Shin W, Kim HJ. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A. 2018, 115:E10539-47. 10.1073\/pnas.1810819115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation","volume":"74","author":"Mousa OY","year":"2021","unstructured":"Mousa OY, Juran BD, McCauley BM, et al.. Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation. Hepatology. 2021, 74:281-95. 10.1002\/hep.31652","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.12.005","article-title":"Microbial players in primary sclerosing cholangitis: current evidence and concepts","volume":"17","author":"\u00d6zdirik B","year":"2024","unstructured":"\u00d6zdirik B, Schnabl B. Microbial players in primary sclerosing cholangitis: current evidence and concepts. Cell Mol Gastroenterol Hepatol. 2024, 17:423-38. 10.1016\/j.jcmgh.2023.12.005","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2024.100315","article-title":"Gut microbiota and bile acids: metabolic interactions and impacts on diabetic kidney disease","volume":"7","author":"Liu P","year":"2024","unstructured":"Liu P, Jin M, Hu P, et al.. Gut microbiota and bile acids: metabolic interactions and impacts on diabetic kidney disease. Curr Res Microb Sci. 2024, 7:100315. 10.1016\/j.crmicr.2024.100315","journal-title":"Curr Res Microb Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000591","article-title":"Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: a human pilot study","volume":"51","author":"Assis DN","year":"2017","unstructured":"Assis DN, Abdelghany O, Cai SY, et al.. Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: a human pilot study. J Clin Gastroenterol. 2017, 51:e11-6. 10.1097\/MCG.0000000000000591","journal-title":"J Clin Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.04.028","article-title":"Treatment of primary sclerosing cholangitis","volume":"53","author":"Floreani A","year":"2021","unstructured":"Floreani A, De Martin S. Treatment of primary sclerosing cholangitis. Dig Liver Dis. 2021, 53:1531-8. 10.1016\/j.dld.2021.04.028","journal-title":"Dig Liver Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00068S","article-title":"Current therapeutics in primary sclerosing cholangitis","volume":"11","author":"Tan N","year":"2023","unstructured":"Tan N, Lubel J, Kemp W, Roberts S, Majeed A. Current therapeutics in primary sclerosing cholangitis. J Clin Transl Hepatol. 2023, 11:1267-81. 10.14218\/JCTH.2022.00068S","journal-title":"J Clin Transl Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2330738","article-title":"Novel preclinical developments of the primary sclerosing cholangitis treatment landscape","volume":"33","author":"Sohal A","year":"2024","unstructured":"Sohal A, Kowdley KV. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert Opin Investig Drugs. 2024, 33:335-45. 10.1080\/13543784.2024.2330738","journal-title":"Expert Opin Investig Drugs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000538493","article-title":"Gut microbiota in primary sclerosing cholangitis: from prognostic role to therapeutic implications","volume":"42","author":"Maccauro V","year":"2024","unstructured":"Maccauro V, Fianchi F, Gasbarrini A, Ponziani FR. Gut microbiota in primary sclerosing cholangitis: from prognostic role to therapeutic implications. Dig Dis. 2024, 42:369-79. 10.1159\/000538493","journal-title":"Dig Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003174","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis therapy landscape","volume":"120","author":"Bhushan S","year":"2025","unstructured":"Bhushan S, Sohal A, Kowdley KV. Primary biliary cholangitis and primary sclerosing cholangitis therapy landscape. Am J Gastroenterol. 2025, 120:151-8. 10.14309\/ajg.0000000000003174","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346978-cholecystectomy-is-linked-to-worse-clinical-outcomes-in-primary-sclerosing-cholangitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:24:19Z","timestamp":1741332259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346978-cholecystectomy-is-linked-to-worse-clinical-outcomes-in-primary-sclerosing-cholangitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.80184","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}